FILE:ABC/ABC-8K-20090909080927.txt.gz
EVENTS:	Other Events
TEXT:
ITEM: Other Events
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
o
o
o
o
 
 
 
Item 8.01. Other Events.  
On September 10, 2009, representatives of AmerisourceBergen Corporation (the "Registrant") will attend the Robert W. Baird & Company, Inc. 2009 Healthcare Conference in New York. Speaking at the Conference will be Executive Vice President and Chief Financial Officer Michael D. DiCandilo and Executive Vice President and President AmerisourceBergen Drug Corporation Steven H. Collis. At the Conference, Mr. DiCandilo intends to reaffirm the Registrant's fiscal year 2009 guidance. Accordingly, the Registrant continues to expect diluted earnings per share from continuing operations for fiscal year 2009 to be at the higher end of the range of $1.59 to $1.65, an increase of 10 percent to 15 percent over the split-adjusted $1.44 in fiscal year 2008.
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AMERISOURCEBERGEN CORPORATION
Date: September 9, 2009
Name:   Michael D. DiCandilo Title:     Executive Vice President
By:        s/ Michael D. DiCandilo              
/
and Chief Financial Officer


